LYDIA WILLIAMS: Open Payments
NPI 1487246765 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 38 payments from 10 companies in 2025. Trend: 2023 $440 · 2024 $645 · 2025 $771
Food & beverage: $672Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $190 |
| Biogen, Inc. | 8 | $171 |
| Sumitomo Pharma America, Inc. | 9 | $159 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $62 |
| Organon LLC | 4 | $55 |
| Hologic Sales and Service, LLC | 2 | $44 |
| SHIELD THERAPEUTICS INC | 1 | $26 |
| Dexcom, Inc. | 1 | $24 |
| Innovation Technologies Inc | 1 | $22 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: ZURZUVAE, MYFEMBREE, Veozah, APTIMA, NEXPLANON, ACCRUFER, Dexcom G6 Transmitter, IRRISEPT.
Industry payments across AR — which companies pay providers there.
